Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexycu for inflammation after cataract surgery
NCT01606735Phase 2Completed
- Sponsor
- Icon Bioscience, Inc.
- Start
- Apr 2012
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
A Phase 2 trial of IBI-10090 in post-operative ocular inflammation, sponsored by Icon Bioscience, Inc.. Started Apr 2012; status: completed.
02
Drugs
IBI-10090
03
Conditions
post-operative ocular inflammation
Beyond the preview
Go deeper on NCT01606735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606735.